isobutyramide has been researched along with Anemia, Sickle Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dover, GJ; Faller, DV; Ginder, GD; Olivieri, NF; Perrine, SP; Vichinsky, EP | 1 |
| Daftari, P; Dover, GH; Faller, DV; Jin, Y; Mays, A; Perrine, SP; Walsh, CT | 1 |
| Gu, LH; Huisman, TH; Jansen, R; Saleh, AW; van Goethem, A; Velvis, HJ | 1 |
1 trial(s) available for isobutyramide and Anemia, Sickle Cell
| Article | Year |
|---|---|
Isobutyramide therapy in patients with sickle cell anemia.
Topics: Adult; Amides; Anemia, Sickle Cell; Female; Fetal Hemoglobin; Globins; Humans; Hydroxyurea; L-Lactate Dehydrogenase; Male; Middle Aged | 1995 |
2 other study(ies) available for isobutyramide and Anemia, Sickle Cell
| Article | Year |
|---|---|
Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders.
Topics: Adolescent; Adult; Amides; Anemia, Sickle Cell; Animals; Arginine; beta-Thalassemia; Butyrates; Child; Child, Preschool; Fetal Hemoglobin; Globins; Humans; Promoter Regions, Genetic | 1994 |
Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo.
Topics: Administration, Oral; Amides; Anemia, Sickle Cell; Animals; beta-Thalassemia; Erythroid Precursor Cells; Fetal Hemoglobin; Gene Expression Regulation; Genes, Reporter; Globins; Humans; Male; Papio; Promoter Regions, Genetic; Transfection | 1994 |